Glycaemic impact of treatment intensification in patients with type 2 diabetes uncontrolled with oral antidiabetes drugs or basal insulin

Endocrinology, Diabetes & Metabolism
Erin K BuysmanLesley-Ann Miller-Wilson

Abstract

To investigate the impact of treatment intensification (TI) on glycaemic outcomes in patients with type 2 diabetes with glycated haemoglobin A1c (A1C) ≥7% after ≥6 months of treatment with 2 oral antidiabetes drugs (OADs) or basal insulin (BI). Data were extracted from the Optum administrative claims database from 1 January 2009 to 31 August 2015. Patients with TI ≤6 months after the first A1C ≥7% (index date) were compared with patients with no TI (NTI). TI included addition of OAD, GLP-1 receptor agonist or premixed insulin in OAD and BI cohorts, addition of BI and/or bolus insulin in the OAD cohort and addition of bolus insulin or increasing BI dose in the BI cohort. Change from the index A1C value and hypoglycaemia events was compared at 12 months after TI after adjusting for confounders. A total of 3990/28 123 (14.2%) and 10 425/16 140 (65%) of eligible adults in the OAD and BI cohorts, respectively, underwent TI. These patients showed greater adjusted A1C change vs NTI patients (OAD cohort: -0.59% vs -0.25%; BI cohort: -0.30% vs -0.16%; P < .001 for both comparisons), but with higher hypoglycaemia rates (OAD cohort: odds ratio [OR] 1.68; P < .001; BI cohort: OR: 1.23; P = .004) at follow-up. Clinical inertia appears to be...Continue Reading

References

Aug 16, 2005·The Diabetes Educator·David C ZiemerLawrence S Phillips
Jun 15, 2007·QJM : Monthly Journal of the Association of Physicians·W S LeslieM E J Lean
Apr 3, 2008·BMC Endocrine Disorders·Adit A GindeCarlos A Camargo
Sep 16, 2009·International Journal of Clinical Practice. Supplement·T Kunt, F J Snoek
Jan 25, 2012·Diabetic Medicine : a Journal of the British Diabetic Association·B T BlakT Ivanyi
Feb 19, 2013·Diabetes Care·Sarah Stark CasagrandeCatherine C Cowie
May 16, 2014·Diabetes Care·Beverley BalkauNick Freemantle
Aug 19, 2014·Journal of Diabetes and Its Complications·Bernard CharbonnelMelanie Davies
Aug 26, 2014·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Mehul R DalalAndres DiGenio
Sep 25, 2014·Diabetic Medicine : a Journal of the British Diabetic Association·A ZafarK Khunti
May 11, 2016·Diabetes, Obesity & Metabolism·A Z Fu, J J Sheehan
Jun 10, 2016·Diabetic Medicine : a Journal of the British Diabetic Association·R W ThomsenS P Johnsen
Jan 18, 2017·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Alan J GarberGuillermo E Umpierrez

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

© 2022 Meta ULC. All rights reserved